Submission guidelines for abstract submission to the Stemcell 2025:
Submission Portal Submit your abstract through the designated online submission gate handed on the webinar website.
Abstract Format Prepare your abstract according to the specified format guidelines, including word count, fountain size, and formatting style.
Title give a terse and descriptive title that directly reflects the content of your exploration.
Authors List all authors' names, confederations, and contact information. Indicate the presenting author if different from the primary author.
Abstract Content easily state the objects, styles, results, and conclusions of your exploration within the abstract. Avoid bowdlerization’s and undetermined acronyms.
Keywords Include a list of applicable keywords or expressions to grease indexing and search ability.
Clarity and Conciseness Write your abstract in clear, terse language, avoiding gratuitous slang or specialized terms that may be unclear to compendiums.
Applicability insure that your abstract aligns with the webinar theme and focuses on motifs applicable to Stemcell 2025.
Plates and Tables If applicable, include applicable plates, tables, or images to enhance understanding of your exploration findings. insure they're high quality and easily labelled.
References If citing former exploration or literature, include applicable references following the specified citation style.
Submission Deadline Submit your abstract by the specified deadline to be considered for donation at the webinar. Late cessions may not be accepted.
Evidence Upon successful submission, you should admit an evidence dispatch or announcement admitting your epitome.
Review Process objectifications will suffer a peer review process by the webinar scientific commission. announcement of acceptance or rejection will be communicated within the specified timeframe.
Donation Format If your epitome is accepted, follow the guidelines handed for oral or bill donation, including donation length, formatting conditions, and session scheduling.
NOTE: Download the abstract template from the below for submission reference.
Clinging to these submission guidelines will help insure that your epitome is duly formatted, applicable, and competitive for consideration at the Stemcell 2025.
The Alarm's Mike Peters Seeks Stem Cell Donor Amid Health Battle
2024-12-19 - 2024-12
Content: Mike Peters, lead singer of the rock band The Alarm, is urgently searching for a stem cell donor after being diagnosed with Richter's syndrome, a transformation of chronic lymphocytic leukemia into an aggressive lymphoma. Peters has launched the "One in a Million" campaign through the Love Hope Strength foundation to find a matching donor. Despite his health challenges, Peters remains hopeful and continues to engage with his music, recently releasing a new music video.
Mesoblast's Stem Cell Therapy Approved for Pediatric GVHD
2024-12-20 - 2024-12
Biotech company Mesoblast has received FDA approval for Ryoncil, the first treatment for children with acute graft versus host disease (GVHD) unresponsive to steroids. This approval marks a significant advancement in cell therapy, offering a new treatment option for a condition affecting many bone-marrow transplant patients.
U.S. Stem Cell Therapy Market Revenue to Attain USD 17.70 Bn by 2033
2024-12-26 - 2024-12
U.S. Stem Cell Therapy Market Revenue and Trends 2023 to 2033
The U.S. stem cell therapy market revenue surpassed USD 5.99 billion in 2024 and is predicted to attain around USD 17.70 billion by 2033, growing at a CAGR of 12.79%. The rising prevalence of chronic diseases and innovations in stem cell-based therapies drive the growth of the market.
U.S. Stem Cell Therapy Market Statistics
Market Overview
Stem cell therapy is an ideal approach to eliminate generative deficiencies by replacing diseased cells. It replaces tissue or organs damaged by age, disease, or injuries. Stem cells have the ability to regenerate new tissues in the human body and, hence, are mostly used for therapeutic purposes in tissue regeneration and repair.
The U.S. stem cell therapy market has been witnessing rapid growth due to the increasing cases of osteoarthritis and musculoskeletal diseases. Stem cell therapy has the potential to heal wounds and is also under development for treating diseases like rheumatoid arthritis, Crohn's disease, and multiple sclerosis. In addition, the increasing funding by private and commercial sectors in stem cell therapy and innovations in technologies like 3D printing propel the market for U.S. stem cell therapy. The rising demand for personalized therapies that possess fewer side effects on the patients and the increasing use of CRISPR technology further contribute to market expansion.
